Topical Drug Delivery Market Research Report by Product (Liquid Formulations, Semi-Solid Formulations, Solid Formulations, and Transdermal Products), by Rout to Administration (Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, and Vaginal Drug Delivery), by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Topical Drug Delivery Market is expected to grow from USD 95,089.84 Million in 2020 to USD 126,194.15 Million by the end of 2025.
2. The Global Topical Drug Delivery Market is expected to grow from EUR 83,376.58 Million in 2020 to EUR 110,649.42 Million by the end of 2025.
3. The Global Topical Drug Delivery Market is expected to grow from GBP 74,121.96 Million in 2020 to GBP 98,367.58 Million by the end of 2025.
4. The Global Topical Drug Delivery Market is expected to grow from JPY 10,148,496.51 Million in 2020 to JPY 13,468,113.60 Million by the end of 2025.
5. The Global Topical Drug Delivery Market is expected to grow from AUD 138,083.10 Million in 2020 to AUD 183,250.69 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Topical Drug Delivery to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Topical Drug Delivery Market studied across Liquid Formulations, Semi-Solid Formulations, Solid Formulations, and Transdermal Products. The Liquid Formulations further studied across Solutions and Suspensions. The Semi-Solid Formulations further studied across Creams, Gels, Lotions, Ointments, and Pastes. The Solid Formulations further studied across Powders and Suppositories. The Transdermal Products further studied across Transdermal Patches and Transdermal Semi-Solids.
Based on Rout to Administration, the Topical Drug Delivery Market studied across Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, and Vaginal Drug Delivery.
Based on End-User, the Topical Drug Delivery Market studied across Burn Centers, Home Care Settings, and Hospitals and Clinics.
Based on Geography, the Topical Drug Delivery Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Topical Drug Delivery Market including Absorption Systems LLC, Bausch Health Companies Inc, Bayer AG, Cipla Limited, Crescita Therapeutics Inc., GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co., Inc., Janssen Global Services, LLC, MedPharm Ltd., Merck & Co., Inc., Mylan N.V., Nestl? S.A., Novartis International AG, and The Lubrizol Corporation.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Topical Drug Delivery Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Topical Drug Delivery Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Topical Drug Delivery Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Topical Drug Delivery Market?
4. What is the competitive strategic window for opportunities in the Global Topical Drug Delivery Market?
5. What are the technology trends and regulatory frameworks in the Global Topical Drug Delivery Market?
6. What are the modes and strategic moves considered suitable for entering the Global Topical Drug Delivery Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Topical Drug Delivery Market is expected to grow from USD 95,089.84 Million in 2020 to USD 126,194.15 Million by the end of 2025.
2. The Global Topical Drug Delivery Market is expected to grow from EUR 83,376.58 Million in 2020 to EUR 110,649.42 Million by the end of 2025.
3. The Global Topical Drug Delivery Market is expected to grow from GBP 74,121.96 Million in 2020 to GBP 98,367.58 Million by the end of 2025.
4. The Global Topical Drug Delivery Market is expected to grow from JPY 10,148,496.51 Million in 2020 to JPY 13,468,113.60 Million by the end of 2025.
5. The Global Topical Drug Delivery Market is expected to grow from AUD 138,083.10 Million in 2020 to AUD 183,250.69 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Topical Drug Delivery to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Topical Drug Delivery Market studied across Liquid Formulations, Semi-Solid Formulations, Solid Formulations, and Transdermal Products. The Liquid Formulations further studied across Solutions and Suspensions. The Semi-Solid Formulations further studied across Creams, Gels, Lotions, Ointments, and Pastes. The Solid Formulations further studied across Powders and Suppositories. The Transdermal Products further studied across Transdermal Patches and Transdermal Semi-Solids.
Based on Rout to Administration, the Topical Drug Delivery Market studied across Dermal Drug Delivery, Nasal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, and Vaginal Drug Delivery.
Based on End-User, the Topical Drug Delivery Market studied across Burn Centers, Home Care Settings, and Hospitals and Clinics.
Based on Geography, the Topical Drug Delivery Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Topical Drug Delivery Market including Absorption Systems LLC, Bausch Health Companies Inc, Bayer AG, Cipla Limited, Crescita Therapeutics Inc., GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co., Inc., Janssen Global Services, LLC, MedPharm Ltd., Merck & Co., Inc., Mylan N.V., Nestl? S.A., Novartis International AG, and The Lubrizol Corporation.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Topical Drug Delivery Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Topical Drug Delivery Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Topical Drug Delivery Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Topical Drug Delivery Market?
4. What is the competitive strategic window for opportunities in the Global Topical Drug Delivery Market?
5. What are the technology trends and regulatory frameworks in the Global Topical Drug Delivery Market?
6. What are the modes and strategic moves considered suitable for entering the Global Topical Drug Delivery Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. End-User Outlook
3.4. Product Outlook
3.5. Rout to Administration Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of skin diseases
5.1.1.2. Rising prevalence of eye diseases
5.1.1.3. High incidence of burn injuries
5.1.1.4. Increasing prevalence of diabetes
5.1.2. Restraints
5.1.2.1. Preference for alternative modes of drug delivery
5.1.3. Opportunities
5.1.3.1. Delivery of biologics through the transdermal route
5.1.3.2. Self-administration and home care
5.1.4. Challenges
5.1.4.1. Technical barriers related to skin irritation and permeability
5.1.4.2. Drug failures and product recalls
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY PRODUCT
6.1. Introduction
6.2. Liquid Formulations
6.2.1. Solutions
6.2.2. Suspensions
6.3. Semi-Solid Formulations
6.3.1. Creams
6.3.2. Gels
6.3.3. Lotions
6.3.4. Ointments
6.3.5. Pastes
6.4. Solid Formulations
6.4.1. Powders
6.4.2. Suppositories
6.5. Transdermal Products
6.5.1. Transdermal Patches
6.5.2. Transdermal Semi-Solids
7. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY ROUT TO ADMINISTRATION
7.1. Introduction
7.2. Dermal Drug Delivery
7.3. Nasal Drug Delivery
7.4. Ophthalmic Drug Delivery
7.5. Rectal Drug Delivery
7.6. Vaginal Drug Delivery
8. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END-USER
8.1. Introduction
8.2. Burn Centers
8.3. Home Care Settings
8.4. Hospitals and Clinics
9. AMERICAS TOPICAL DRUG DELIVERY MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Absorption Systems LLC
13.2. Bausch Health Companies Inc
13.3. Bayer AG
13.4. Cipla Limited
13.5. Crescita Therapeutics Inc.
13.6. GlaxoSmithKline plc
13.7. Glenmark Pharmaceuticals Limited
13.8. Hisamitsu Pharmaceutical Co., Inc.
13.9. Janssen Global Services, LLC
13.10. MedPharm Ltd.
13.11. Merck & Co., Inc.
13.12. Mylan N.V.
13.13. Nestl? S.A.
13.14. Novartis International AG
13.15. The Lubrizol Corporation
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. End-User Outlook
3.4. Product Outlook
3.5. Rout to Administration Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of skin diseases
5.1.1.2. Rising prevalence of eye diseases
5.1.1.3. High incidence of burn injuries
5.1.1.4. Increasing prevalence of diabetes
5.1.2. Restraints
5.1.2.1. Preference for alternative modes of drug delivery
5.1.3. Opportunities
5.1.3.1. Delivery of biologics through the transdermal route
5.1.3.2. Self-administration and home care
5.1.4. Challenges
5.1.4.1. Technical barriers related to skin irritation and permeability
5.1.4.2. Drug failures and product recalls
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY PRODUCT
6.1. Introduction
6.2. Liquid Formulations
6.2.1. Solutions
6.2.2. Suspensions
6.3. Semi-Solid Formulations
6.3.1. Creams
6.3.2. Gels
6.3.3. Lotions
6.3.4. Ointments
6.3.5. Pastes
6.4. Solid Formulations
6.4.1. Powders
6.4.2. Suppositories
6.5. Transdermal Products
6.5.1. Transdermal Patches
6.5.2. Transdermal Semi-Solids
7. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY ROUT TO ADMINISTRATION
7.1. Introduction
7.2. Dermal Drug Delivery
7.3. Nasal Drug Delivery
7.4. Ophthalmic Drug Delivery
7.5. Rectal Drug Delivery
7.6. Vaginal Drug Delivery
8. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END-USER
8.1. Introduction
8.2. Burn Centers
8.3. Home Care Settings
8.4. Hospitals and Clinics
9. AMERICAS TOPICAL DRUG DELIVERY MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Absorption Systems LLC
13.2. Bausch Health Companies Inc
13.3. Bayer AG
13.4. Cipla Limited
13.5. Crescita Therapeutics Inc.
13.6. GlaxoSmithKline plc
13.7. Glenmark Pharmaceuticals Limited
13.8. Hisamitsu Pharmaceutical Co., Inc.
13.9. Janssen Global Services, LLC
13.10. MedPharm Ltd.
13.11. Merck & Co., Inc.
13.12. Mylan N.V.
13.13. Nestl? S.A.
13.14. Novartis International AG
13.15. The Lubrizol Corporation
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. GLOBAL TOPICAL DRUG DELIVERY MARKET: SCORES
TABLE 118. GLOBAL TOPICAL DRUG DELIVERY MARKET: BUSINESS STRATEGY
TABLE 119. GLOBAL TOPICAL DRUG DELIVERY MARKET: PRODUCT SATISFACTION
TABLE 120. GLOBAL TOPICAL DRUG DELIVERY MARKET: RANKING
TABLE 121. GLOBAL TOPICAL DRUG DELIVERY MARKET: MERGER & ACQUISITION
TABLE 122. GLOBAL TOPICAL DRUG DELIVERY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 123. GLOBAL TOPICAL DRUG DELIVERY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 124. GLOBAL TOPICAL DRUG DELIVERY MARKET: INVESTMENT & FUNDING
TABLE 125. GLOBAL TOPICAL DRUG DELIVERY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 126. GLOBAL TOPICAL DRUG DELIVERY MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. GLOBAL TOPICAL DRUG DELIVERY MARKET: SCORES
TABLE 118. GLOBAL TOPICAL DRUG DELIVERY MARKET: BUSINESS STRATEGY
TABLE 119. GLOBAL TOPICAL DRUG DELIVERY MARKET: PRODUCT SATISFACTION
TABLE 120. GLOBAL TOPICAL DRUG DELIVERY MARKET: RANKING
TABLE 121. GLOBAL TOPICAL DRUG DELIVERY MARKET: MERGER & ACQUISITION
TABLE 122. GLOBAL TOPICAL DRUG DELIVERY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 123. GLOBAL TOPICAL DRUG DELIVERY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 124. GLOBAL TOPICAL DRUG DELIVERY MARKET: INVESTMENT & FUNDING
TABLE 125. GLOBAL TOPICAL DRUG DELIVERY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 126. GLOBAL TOPICAL DRUG DELIVERY MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL TOPICAL DRUG DELIVERY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TOPICAL DRUG DELIVERY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2025
FIGURE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 33. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2025
FIGURE 35. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
FIGURE 41. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2025
FIGURE 43. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 46. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 55. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 57. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 69. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. GLOBAL TOPICAL DRUG DELIVERY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 81. GLOBAL TOPICAL DRUG DELIVERY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 82. GLOBAL TOPICAL DRUG DELIVERY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 83. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE
FIGURE 1. GLOBAL TOPICAL DRUG DELIVERY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TOPICAL DRUG DELIVERY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL TOPICAL DRUG DELIVERY MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL TOPICAL DRUG DELIVERY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 15. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PRODUCT, 2025
FIGURE 17. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LIQUID FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLUTIONS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUSPENSIONS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SEMI-SOLID FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY CREAMS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY GELS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY LOTIONS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OINTMENTS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY PASTES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SOLID FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY POWDERS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY SUPPOSITORIES, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PRODUCTS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL PATCHES, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL SEMI-SOLIDS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 33. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY ROUT TO ADMINISTRATION, 2025
FIGURE 35. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY DERMAL DRUG DELIVERY, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY NASAL DRUG DELIVERY, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY OPHTHALMIC DRUG DELIVERY, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY RECTAL DRUG DELIVERY, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY VAGINAL DRUG DELIVERY, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
FIGURE 41. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY END-USER, 2025
FIGURE 43. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY BURN CENTERS, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE, BY HOSPITALS AND CLINICS, 2020 VS 2025 (USD MILLION)
FIGURE 46. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 47. AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 49. ARGENTINA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. BRAZIL TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. CANADA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. MEXICO TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. UNITED STATES TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 55. ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 57. AUSTRALIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. CHINA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. INDIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. INDONESIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. JAPAN TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. MALAYSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. PHILIPPINES TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. THAILAND TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 69. FRANCE TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. GERMANY TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. ITALY TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. NETHERLANDS TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. QATAR TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. RUSSIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. SAUDI ARABIA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 77. SPAIN TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 78. UNITED ARAB EMIRATES TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 79. UNITED KINGDOM TOPICAL DRUG DELIVERY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. GLOBAL TOPICAL DRUG DELIVERY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 81. GLOBAL TOPICAL DRUG DELIVERY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 82. GLOBAL TOPICAL DRUG DELIVERY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 83. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE
